Neurofibromatosis 1
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
Neurofibromatosis 1 (NF1) is an autosomal dominant disorder caused by genetic alterations of the NF1 gene on 17q11.2.
|
11857752 |
2002 |
Neurofibromatosis 1
|
1.000 |
Biomarker
|
disease |
BEFREE |
NF1 did not recombine with either TH17.19 or HHH202 in any of the informative meioses surveyed (maximum lod scores of 17.04 and 7.21, respectively, at a recombination fraction of .00), indicating that these markers map very close to the NF1 gene.
|
2491779 |
1989 |
Neurofibromatosis 1
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
Microdeletions of the entire NF1 gene and surrounding genomic region occur in about 5% of patients with neurofibromatosis 1 (NF1).
|
26111455 |
2016 |
Neurofibromatosis 1
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
Here, the known somatic mutational spectrum for the NF1 gene in a range of NF1-associated neoplasms - including peripheral nerve sheath tumours (neurofibromas), malignant peripheral nerve sheath tumours, gastrointestinal stromal tumours, gastric carcinoid, juvenile myelomonocytic leukaemia, glomus tumours, astrocytomas and phaeochromocytomas - have been collated and analysed.
|
22155606 |
2011 |
Neurofibromatosis 1
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
The high rate of NF1 allele loss in NF1-associated pilocytic astrocytomas suggests a tumor initiating or promoting action of the NF1 gene in these patients.
|
11556548 |
2001 |
Neurofibromatosis 1
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
In this article, we report the cases of three children who (1) had manifested mildly different symptomatic neuropathy (twins, aged 4 years; and a boy, aged 9 years) associated with massive, symmetrical neurofibromas; (2) had few café-au-lait spots with irregular margins and pale brown pigmentation; (3) were presented with, at brain magnetic resonance imaging (MRI), bilateral, NF1-like high-signal abnormalities in the basal ganglia; (4) yielded missense NF1 gene mutations in exon 39; and (5) had unaffected parents with negative NF1 genetic testing as well as discuss 12 families and 20 sporadic and 5 additional cases that presented spinal neurofibromatosis within classical NF1 families (53 cases) that were reported in the literature.
|
23780384 |
2013 |
Neurofibromatosis 1
|
1.000 |
Biomarker
|
disease |
BEFREE |
Loss of neurofibromin in adrenal gland tumors from patients with neurofibromatosis type I.
|
7519874 |
1994 |
Neurofibromatosis 1
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
Recurrence of a nonsense mutation in the NF1 gene causing classical neurofibromatosis type 1.
|
1757093 |
1991 |
Neurofibromatosis 1
|
1.000 |
Biomarker
|
disease |
BEFREE |
Mapping of the EVI2 gene between the translocation breakpoints of two patients with neurofibromatosis type 1 (NF1), combined with the likely role of its murine homolog in neoplastic disease, implicates EVI2 as a possible candidate for the NF1 gene.
|
2117566 |
1990 |
Neurofibromatosis 1
|
1.000 |
Biomarker
|
disease |
BEFREE |
The NF1 gene has been identified and direct testing for the NF1 mutation is now possible.
|
8104099 |
1993 |
Neurofibromatosis 1
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
Anorectal malignant melanoma in NF1 is extremely rare, and genetic studies of the NF1 gene in such patients have not been reported.
|
11706558 |
2001 |
Neurofibromatosis 1
|
1.000 |
Biomarker
|
disease |
BEFREE |
We thus identify Notch as an Nf1 effector regulating myelin structure and behavior in a RASopathy and suggest that inhibition of Notch signaling may be a therapeutic strategy for NF1.
|
28423318 |
2017 |
Neurofibromatosis 1
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
Defects in the NF1 gene have been implicated in the inherited disorder neurofibromatosis type 1, which is characterized by several developmental abnormalities including an increased frequency of benign and malignant tumours of neural crest origin (neurofibromas and neurofibrosarcomas respectively).
|
1570015 |
1992 |
Neurofibromatosis 1
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
If we assume that dual-color FISH analysis is sensitive enough to detect the majority of large somatic deletions present, then other mutational mechanisms affecting the NF1 gene are probably involved in neurofibroma formation, and other tumor suppressor genes may play an important role in NF1 tumorigenesis.
|
15066327 |
2004 |
Neurofibromatosis 1
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
Most patients with neurofibromatosis (NF1) are endowed with heterozygous mutations in the NF1 gene.
|
18160797 |
2007 |
Neurofibromatosis 1
|
1.000 |
Biomarker
|
disease |
BEFREE |
These results emphasise the role of the NF1 gene in the pathogenesis of breast cancer and a need for active follow-up for breast cancer in women with NF1.
|
27931045 |
2017 |
Neurofibromatosis 1
|
1.000 |
AlteredExpression
|
disease |
BEFREE |
The undetectable or reduced level of neurofibromin in the tumours obtained from neurofibromatosis type 1 patients suggests that this deficiency is closely related to their tumourigenesis.
|
7614817 |
1995 |
Neurofibromatosis 1
|
1.000 |
Biomarker
|
disease |
BEFREE |
About 5% of patients with neurofibromatosis type 1 (NF1) bear constitutional microdeletions that encompass NF1 (neurofibromin 1) and neighboring genes.
|
23386700 |
2013 |
Neurofibromatosis 1
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
The NF1 gene, which is responsible for the susceptibility to neurofibromatosis type 1, has recently been isolated.
|
1909900 |
1991 |
Neurofibromatosis 1
|
1.000 |
Biomarker
|
disease |
BEFREE |
Over the past decade, substantial insight into the biological function of the tumor suppressors neurofibromin (NF1) and Merlin (NF2) has been gained.
|
25490687 |
2015 |
Neurofibromatosis 1
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
Malignant peripheral nerve sheath tumors (MPNST) in neurofibromatosis type 1 (NF1): diagnostic findings on magnetic resonance images and mutation analysis of the NF1 gene.
|
16033085 |
2005 |
Neurofibromatosis 1
|
1.000 |
AlteredExpression
|
disease |
BEFREE |
Neurofibromin, encoded by the Nf1 gene, functions as a GTPase-activating protein (GAP) whose mutation leads to activation of wt-RAS and mitogen-activated protein kinase (MAPK) signaling in neurofibromatosis type I (NF1) patients' tumors.
|
23423222 |
2013 |
Neurofibromatosis 1
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
This is the first reported case of monozygotic twins discordant for NF1 in whom mosaicism for a postzygotic NF1 gene mutation has been observed in the affected but not the unaffected twin.
|
21618341 |
2011 |
Neurofibromatosis 1
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
In the present study, we investigated the clinical characteristics and NF1 gene mutation analysis of 3 unrelated Indian families with neurofibromatosis type 1.
|
29680440 |
2018 |
Neurofibromatosis 1
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
Neurofibromatosis type 1 (NF1) is an autosomal dominant disease caused by NF1 gene mutation, and clinically characterized by multiple cutaneous neurofibromas and café-au-lait spots.
|
29079545 |
2018 |